In a filing, Apogee Therapeutics Inc. revealed its Chief Executive Officer HENDERSON MICHAEL THOMAS unloaded Company’s shares for reported $0.56 million on Jul 05 ’24. In the deal valued at $37.26 per share,15,000 shares were sold. As a result of this transaction, HENDERSON MICHAEL THOMAS now holds 1,474,487 shares worth roughly $64.98 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Dambkowski Carl sold 5,995 shares, generating $225,418 in total proceeds. Upon selling the shares at $37.60, the Chief Medical Officer now owns 294,793 shares.
BofA Securities initiated its Apogee Therapeutics Inc. [APGE] rating to a Buy in a research note published on May 10, 2024; the price target was $80. A number of analysts have revised their coverage, including BTIG Research’s analysts, who began to cover the stock in mid December with a ‘”a Buy”‘ rating. Wedbush began covering APGE with “an Outperform” recommendation on August 08, 2023. TD Cowen started covering the stock on August 08, 2023. It rated APGE as “an Outperform”.
Price Performance Review of APGE
On Friday, Apogee Therapeutics Inc. [NASDAQ:APGE] saw its stock fall -3.67% to $44.07. Over the last five days, the stock has lost -11.77%. Apogee Therapeutics Inc. shares have risen nearly 57.73% since the year began. Nevertheless, the stocks have risen 111.77% over the past one year. While a 52-week high of $72.29 was reached on 03/13/24, a 52-week low of $14.19 was recorded on 01/08/24. SMA at 50 days reached $44.01, while 200 days put it at $39.25. A total of 0.5 million shares were traded, compared to the trading of 0.3 million shares in the previous session.
Levels Of Support And Resistance For APGE Stock
The 24-hour chart illustrates a support level at 42.73, which if violated will result in even more drops to 41.39. On the upside, there is a resistance level at 44.93. A further resistance level may holdings at 45.79. The Relative Strength Index (RSI) on the 14-day chart is 44.39, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -2.21, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 82.07%. Stochastics%K at 27.36% indicates the stock is a holding.
The most recent change occurred on August 08, 2023 when Stifel began covering the stock and recommended ‘”a Buy”‘ rating along with a $34 price target.
